Overview
Erythropoietin and Early Iron Supplement and Retinopathy of Prematurity
Status:
Unknown status
Unknown status
Trial end date:
2006-12-01
2006-12-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
To evaluate the possibility that erythropoietin with early iron supplementation may induce retinopathy of prematurity or worsen this disease. In addition risk factors for the development of ROP will be checked.Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Sheba Medical CenterTreatments:
Epoetin Alfa
Iron
Criteria
Inclusion Criteria:- all premature infants with birth weight of 1250 grams or less
Exclusion Criteria:
- none